Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CVON

ConvergeOne (CVON) Stock Price, News & Analysis

ConvergeOne logo

About ConvergeOne Stock (NASDAQ:CVON)

Advanced Chart

Key Stats

Today's Range
$12.44
$12.44
50-Day Range
N/A
52-Week Range
$7.95
$12.75
Volume
11,592 shs
Average Volume
268,528 shs
Market Capitalization
$950.42 million
P/E Ratio
32.74
Dividend Yield
0.64%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CVON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvergeOne and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVON Stock News Headlines

Warren Buffett’s #1 AI Stock is Not Even on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008."tc pixel
ICS Announces Its Best-of-Breed Partner Program
C1 Named to Newsweek's America's Greatest Workplaces 2024
See More Headlines

CVON Stock Analysis - Frequently Asked Questions

ConvergeOne Holdings, Inc. (NASDAQ:CVON) posted its earnings results on Tuesday, October, 30th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.09. The firm had revenue of $404.75 million for the quarter, compared to analysts' expectations of $392.71 million. ConvergeOne had a negative trailing twelve-month return on equity of 76.41% and a net margin of 1.60%.

Based on aggregate information from My MarketBeat watchlists, some other companies that ConvergeOne investors own include Bristol Myers Squibb (BMY), Mondi (MNDI), Nektar Therapeutics (NKTR), Weyerhaeuser (WY), Allena Pharmaceuticals (ALNA), Abercrombie & Fitch (ANF) and Best Buy (BBY).

Company Calendar

Last Earnings
10/30/2018
Today
9/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged Software
Sub-Industry
N/A
Current Symbol
NASDAQ:CVON
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.38
Trailing P/E Ratio
32.74
Forward P/E Ratio
14.47
P/E Growth
N/A
Net Income
$290 thousand
Net Margins
1.60%
Pretax Margin
N/A
Return on Equity
-76.41%
Return on Assets
9.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.03
Quick Ratio
0.96

Sales & Book Value

Annual Sales
$918.93 million
Price / Sales
1.03
Cash Flow
$0.74 per share
Price / Cash Flow
16.84
Book Value
$0.11 per share
Price / Book
113.09

Miscellaneous

Outstanding Shares
76,400,000
Free Float
N/A
Market Cap
$950.42 million
Optionable
Not Optionable
Beta
0.45
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CVON) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners